Dr Philip Taylor
Prosiectau fel Prif Ymchwiliwr
1 o 3
- A combination of in silico and in vitro studies to understand the regulation of microglia by the novel Alzheimer’s disease risk gene ATP8B4 (01.10.2023 - 30.09.2026)
- A framework for the use human iPSC-derived microglial cultures in translational platforms (01.10.2021 - 30.03.2025)
- Collective role of myeloid lectins in host-defence and immunity (01.11.2011 - 30.09.2012)
- Control of homeostasis and anti-microbial immunity by the macrophage metabolome (05.05.2015 - 31.05.2019)
- Defining the role of peritoneal dendritic cells in tissue specific immunity and the clinical application of peritoneal dialysis (01.08.2013 - 31.07.2016)
Prosiectau fel Cyd-Ymchwiliwr
1 o 2
- Chemical biological and therapeutic actions of esterified eicosanoids generated by human immune cells: Understanding membrane signalling actions of novel lipid families (01.08.2011 - 31.12.2017)
- Does Abi3 ablation result in more inflammatory microglia and astrocyte profiles in Alzheimer’s Disease model (01.10.2021 - 31.03.2023)
- Establishing the relationship between anti-microbial host defence and the initiation of tissue fibrosis in peritoneal dialysis (01.10.2016 - 31.12.2019)
- Exploring microRNA-mediated regulation of renal macrophage function during kidney injury and fibrosis (01.08.2016 - 31.01.2020)
- Innate pathogen sensing by local unconventional T cells during microbial infections (01.08.2016 - 30.11.2020)
Thomson Reuters Deutschland GmbH
Zur Giesserei 2
D-76227 Karlsruhe | Germany